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The choline-binding protein CbpI from Streptococcus pneumoniae is a 23.4 kDa
protein with no known function. The protein has been successfully puriﬁed
initially using Ni–NTA chromatography and to homogeneity using Q-Sepharose
ion-exchange resin as an afﬁnity column. CbpI was crystallized using PEG 3350
as a precipitant and X-ray crystallographic analysis showed that the crystals
belongedtothetetragonalspacegroupP4,withunit-cellparametersa=b=83.31,
c = 80.29 A ˚ ,  =  =  =9 0  . The crystal contains two molecules in the
asymmetric unit with a solvent content of 55.7% (VM =2 . 7 7A ˚ 3 Da
 1) and shows
a diffraction limit of 3.5 A ˚ .
1. Introduction
Choline-binding proteins are a family of between ten and 15 surface
proteins (dependent on strain; Bergmann & Hammerschmidt, 2006)
from Streptococcus pneumoniae that share a common surface-
attachment domain. This domain facilitates attachment to multiple
choline head units of the teichoic and lipoteichoic acids that are
found throughout the pneumococcal cell wall (Brundish & Baddiley,
1968; Tomasz, 1967) and is comprised of a highly conserved  20-
amino-acid repeat with between two and ten repeats forming the
domain (Yother & White, 1994). Members of the family show diverse
functionality and are often strongly implicated in organism virulence
(Gosink et al., 2000). There are also several family members for which
no function is available and no sequence similarity exists and these
may also be important pneumococcal virulence factors.
CbpI was chosen as part of a pilot structural genomics project at
the University of Glasgow studying potential surface virulence
factors from S. pneumoniae (Wisemann et al., 2001). CbpI is a 211-
amino-acid 23.4 kDa protein of unknown function that contains six
choline-binding repeats (Garcia et al., 1988) located towards the
C-terminus of the protein as identiﬁed by PROSITE (Gattiker et al.,
2002). There is no signiﬁcant sequence similarity between the
N-terminal region and any previously identiﬁed sequence.
We report here the puriﬁcation and crystallization of full-length
CbpI from S. pneumoniae. A crystal structure of CbpI may elucidate
a function for this member of a pathogenically important extra-
cellular protein family.
2. Materials and methods
2.1. Cloning and expression
A PCR product containing the coding region for full-length CbpI
was cloned between the BamHI and HindIII sites of vector pQE-10
(Qiagen) with an in-frame non-cleavable N-terminal His6 tag and
linker (MRGSHHHHHHTDP). Transformation was carried out into
Escherichia coli strain BL21 (DE3) for expression in the cytoplasm
and the cells were grown overnight on LB-agar plates containing
50 mgm l
 1 ampicillin at 310 K. A single colony was picked and grown
in 10 ml LB containing 50 mgm l
 1 ampicillin overnight at 310 K.
Cultures (8   1 l) for induction were inoculated using 1 ml of this
overnight culture and were grown in LB media containing the
selective antibiotic at 293 K. This temperature was essential for
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to an A600 of 0.6, at which point isopropyl thio--d-galactoside
(IPTG) was added to a ﬁnal concentration of 1 mM. Cultures were
grown to an A600 of 1.0 and then harvested by centrifugation at 3500g
and 277 K for 15 min.
2.2. Purification
Cells were resuspended in lysis buffer [50 mM Tris–HCl pH 7.5,
500 mM NaCl, one EDTA-free protease-inhibitor tablet (Roche) per
25 ml] and lysed by sonication (Status US200 with TT13 tip, 10   30 s
bursts at 100% power on ice). Cell debris was pelleted by centrifu-
gation at 8000g and 277 K for 15 min and any residual cell debris was
removed by further centrifugation of the supernatant at 40 000g and
277 K for 20 min. The supernatant was loaded onto a 15 ml Ni–NTA
(Qiagen) column previously equilibrated with 50 mM Tris–HCl pH
7.5, 500 mM NaCl and washed with this buffer until a constant A280
was observed. Protein was eluted with a gradient to 50 mM Tris–HCl
pH 7.5, 500 mM NaCl, 250 mM imidazole and fractions containing
CbpI were pooled.
The charged head unit of Q-Sepharose ion-exchange resin
(Amersham) is a choline-like moiety (Fig. 1) and it proved possible to
use this resin for afﬁnity chromatography in a similar manner to the
approach previously reported using DEAE resin (Sanchez-Puelles et
al., 1990). Protein previously puriﬁed by Ni–NTA afﬁnity was
dialysed into 50 mM Tris–HCl pH 7.5, 150 mM NaCl and loaded onto
a column packed with 50 ml Q-Sepharose resin. This column was then
washed with a gradient to 50 mM Tris–HCl pH 7.5, 1.0 M NaCl to
remove contaminant proteins. CbpI was eluted by a step to 50 mM
Tris–HCl pH 7.5, 500 mM NaCl, 150 mM choline chloride. This
resulted in protein that was judged by eye to be over 95% pure by
SDS–PAGE analysis (Fig. 2).
Aﬁnal polishing step and buffer exchange was carried out using gel
ﬁltration on a 100 ml Superdex 75 column (Amersham) with 50 mM
Tris–HCl pH 7.5, 500 mM NaCl, 50 mM choline chloride and 0.4 mM
DTT. Puriﬁed CbpI was then concentrated to 7 mg ml
 1 (Amicon,
10 kDa molecular-weight cutoff, calculated from a theoretical
extinction coefﬁcient of 89 840 M
 1 cm
 1; Gasteiger et al., 2005).
Approximately 45 mg puriﬁed protein was obtained from 8 l culture.
2.3. Crystallization and data collection
Crystallization trials were performed using the sitting-drop vapour-
diffusion method at 295 K with a protein concentration of 7 mg ml
 1
in 10 mM Tris–HCl pH 7.5, 500 mM NaCl, 50 mM choline chloride.
Initial screening was conducted using Hampton 24-well Cryschem
Plates, a drop volume of 1.5 ml protein solution and 1.5 ml reservoir
solution and a reservoir volume of 750 ml. Drops were mixed by
aspiration. Screening was conducted using Hampton Research
Crystal Screens 1 and 2 (Jancarik & Kim, 1991), Emerald Biosystems
Wizard 1 and 2 and Cryo 1 and 2, Molecular Dimensions Structure
Screen 1 and 2 and a wide range of in-house conditions. Initial
screening revealed a single crystal in an in-house condition
comprising 20%(w/v) PEG 3350, 0.2 M tetraethylammonium
bromide that grew after three months (Fig. 3).
The crystal was ﬂash-cooled to 100 K using dry parafﬁn oil as the
cryoprotectant (Riboldi-Tunnicliffe & Hilgenfeld, 1999) and exposed
to synchrotron X-rays at ESRF beamline ID14.2. Diffraction was
observed to 3.5 A ˚ (Fig. 4). A data set was collected with an oscillation
angle of 0.5  and a summary of data-collection statistics is shown in
Table 1. Data were indexed with LABELIT (Sauter et al., 2004) and
then processed and scaled using the d*TREK package (Pﬂugrath,
1999) in the tetragonal space group P4, with unit-cell parameters
a = b = 83.31, c = 80.29 A ˚ ,  =  =  = 90.0 . The data exhibited high
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Table 1
Summary of data-collection statistics for CbpI.
Values in parentheses are for the highest resolution shell (3.63–3.50 A ˚ ).
X-ray source ID 14.2, ESRF
Wavelength (A ˚ ) 0.9340
Space group P4
Unit-cell parameters
a = b (A ˚ ) 83.31
c (A ˚ ) 80.29
 =  =  ( ) 90.0
Resolution limits (A ˚ ) 28.91–3.50
No. of observations 23177
No. of unique observations 12191
Average redundancy 1.90 (1.94)
Completeness (%) 89.7 (90.3)
hI/(I)i 6.8 (2.1)
Rmerge 0.091 (0.281)
Figure 1
Chemical similarity between Q-Sepharose ion-exchange resin and choline.
Figure 2
NuPAGE 4–12% Bis-Tris gel (Invitrogen) run with NuPAGE MES buffer. Lane 1,
SeeBlue PreStained standard with molecular weights (kDa) given on the left; lane
2, soluble cell fraction; lane 3, Ni–NTA ﬂowthrough; lane 4, Ni–NTAwash; lane 5,
Ni–NTA peak elution/Q-Sepharose load; lane 6, Q-Sepharose elution.mosaicity, with a value of around 3.5  indicated by d*TREK, although
data-processing and scaling statistics were reasonable. The crystal
contains two molecules in the asymmetric unit, with a solvent content
of 55.7% (VM =2 . 7 7A ˚ 3 Da
 1).
Slight variation of the initial crystallization precipitant concentra-
tion and reduction of the pH by addition of 0.1 M Tris–HCl pH 7.0 to
the crystallization solution yielded crystals of improved appearance
with no reduction in growth time (Fig. 3). The diffraction quality of
these new crystals was poor, with resolution limits of around 5 A ˚ and
apparent high mosaicity. Indexing the data gathered from these new
crystals proved impossible.
3. Concluding remarks
Full-length CbpI from S. pneumoniae has been successfully
expressed, puriﬁed and crystallized in space group P4w i t ha
diffraction limit of 3.5 A ˚ . Several structures of other choline-binding
proteins have already been determined (Fernandez-Tornero et al.,
2001; Garau et al., 2005) and work is under way to determine the
structure by molecular replacement using choline-binding domain
fragments from these structures. Work is also in progress to produce a
cleavable His6 tag construct of the protein with the aim of obtaining
crystals of better diffraction quality.
We would like to thank the beamline staff at station ID14.2, ESRF
for help and support during data collection. This work was made
possible by a studentship awarded to NGP by the BBSRC.
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Crystals of CbpI. (a) Initial condition; (b), (c) and (d) pH/precipitant variations.
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